This educational activity is intended to help clinicians identify patients with thyroid eye disease who require intervention for elevated blood glucose levels prior to treatment for thyroid eye disease with the insulin-like growth factor 1 receptor antagonist teprotumumab.

This educational activity will review the role of the corneal nerve in ocular surface health and disease as a foundation for enabling proper diagnosis and for selecting optimal treatment.

In this first case of the series, Dr Walter O. Whitley describes the diagnosis and treatment of a patient with dry eye disease due to meibomian gland dysfunction, along with the latest clinical evidence on new treatments for dry eye disease.

This educational activity features real-world cases of patients with various stages of neurotrophic keratitis and aims to provide ophthalmologists with clinical data and practice pearls to aid in the diagnosis and treatment of neurotrophic keratitis.